ARCHIVES

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Centers Recruting Patients With Mantle Cell Lymphoma

October 29, 2004

Clinical Trials System “Slowly Unraveling,”

March 7, 2008

Tacoma Hospital Finds Cancer DRGs Are Profitable

February 17, 1984

Report Calls For Reinvigorated Cancer Program With Increased Funding, Greater Collaboration.

May 9, 2008

Scientists should lobby Congress to support the project, Broad Institute Director Eric Lander says.

March 18, 2005

New ACS Grants to Fund ‘Critical, Urgent’ Research

April 15, 1977